Conversely, Linnerth-Petrik et al. using murine ID8 ovarian cancer model in vivo, reported that the ablation of AKT1 reduces tumor growth, while the ablation of AKT2 has the opposite effect accelerating tumor growth [40]. The gene discussed is AKT2; the disease is ovarian carcinoma.